# Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage

> **NCT06519617** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Qingwen Tao** · enrollment: 136 (estimated)

## Conditions studied

- Primary Sjögren Syndrome

## Interventions

- **DRUG:** Yi Qi Yang Yin Decoction
- **DRUG:** Hydroxychloroquine Sulfate

## Key facts

- **NCT ID:** NCT06519617
- **Lead sponsor:** Qingwen Tao
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-13
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06519617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06519617, "Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06519617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*